RNA-seq data of LP1 multiple myeloma cell line treated for 6h or 24h with Tasquinimod
Ontology highlight
ABSTRACT: Tasquinimod is a new immunomodulatory treatment for MM that is in phase I/II clinical evaluation in patients with relapsed/refractory MM. In the present study, we evaluated the effect of tasquinimod on MM cells using RNA sequencing to provide more mechanistic insights into the observed tasquinimod-mediated anti-tumor effects.
INSTRUMENT(S): Illumina NovaSeq 6000
ORGANISM(S): Homo sapiens
SUBMITTER:
PROVIDER: E-MTAB-11787 | biostudies-arrayexpress |
SECONDARY ACCESSION(S): ERP138156
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA